Published in

Elsevier, The Lancet, 9962(385), p. 36-42, 2015

DOI: 10.1016/s0140-6736(14)61085-0

Links

Tools

Export citation

Search in Google Scholar

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

Journal article published in 2014 by Ben J. Slotman, Harm van Tinteren ORCID, van Tinteren H Praag JO Knegjens JL El Sharouni SY Hatton M Keijser A Faivre-Finn C Senan S. (joint last authors) Slotman Bj, Tinteren H Praag JO Knegjens JL El Sharouni SY Hatton M Keijser A Faivre-Finn C Senan S. Slotman Bj, John O. Praag, Joost L. Knegjens, Sherif Y. El Sharouni, Matthew Hatton, Astrid Keijser, Corinne Faivre-Finn ORCID, Suresh Senan ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Most patients with extensive stage small-cell lung cancer (ES-SCLC) who undergo chemotherapy, and prophylactic cranial irradiation, have persistent intrathoracic disease. We assessed thoracic radiotherapy for treatment of this patient group.